The Worcester venous thromboembolism study - A population-based study of the clinical epidemiology of venous thromboembolism

被引:328
作者
Spencer, Frederick A.
Emery, Cathy
Lessard, Darleen
Anderson, Frederick
Emani, Sri
Aragam, Jayashri
Becker, Richard C.
Goldberg, Robert J.
机构
[1] McMaster Univ, Dept Med, Fac Hlth Sci, Med Ctr, Hamilton, ON L8N 3Z5, Canada
[2] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA
[3] Fallon Clin Inc, Dept Res, Worcester, MA USA
[4] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
关键词
venous thromboembolism; deep vein thrombosis; pulmonary embolism; population-health;
D O I
10.1111/j.1525-1497.2006.00458.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: While there have been marked advances in diagnostic and therapeutic strategies for venous thromboembolism, our understanding of its clinical epidemiology is based on studies conducted more than a decade ago. OBJECTIVE: The purpose of this observational study was to describe the incidence and attack rates of venous thromboembolism in residents of the Worcester Statistical Metropolitan Area in 1999. We also describe demographic and clinical characteristics, management strategies, and associated hospital and 30-day outcomes. DESIGN AND MEASUREMENTS: The medical records of all residents from Worcester, MA (2000 census = 477,800), diagnosed with International Classification of Diseases, 9th revision (ICD-9) codes consistent with possible venous thromboembolism during 1999 were independently validated, classified, and reviewed by trained abstractors. RESULTS: A total of 587 subjects were enrolled with validated venous thromboembolism. The incidence and attack rates of venous thromboembolism were 104 and 128 per 100,000 population, respectively. Three quarters of patients developed their venous thromboembolism in the outpatient setting - a substantial proportion of these patients had undergone recent surgery or had a recent prior hospitalization. Less than half of the patients received anticoagulant prophylaxis during high-risk periods before their venous thromboembolism. Thirty-day rates of venous thromboembolism recurrence, major bleeding, and mortality were 4.8%, 7.7%, and 6.6%, respectively. CONCLUSION: These data provide insights into recent incidence and attack rates, changing patient profiles, management strategies, and subsequent outcomes in patients with venous thromboembolism. The underutilization of prophylaxis before venous thromboembolism, and relatively high 30-day recurrence rates, suggest a continued need for the improvement of venous thromboembolism prophylaxis and management in the community.
引用
收藏
页码:722 / 727
页数:6
相关论文
共 12 条
  • [1] A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY
    ANDERSON, FA
    WHEELER, HB
    GOLDBERG, RJ
    HOSMER, DW
    PATWARDHAN, NA
    JOVANOVIC, B
    FORCIER, A
    DALEN, JE
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) : 933 - 938
  • [2] CHANGING CLINICAL-PRACTICE - PROSPECTIVE-STUDY OF THE IMPACT OF CONTINUING MEDICAL-EDUCATION AND QUALITY ASSURANCE PROGRAMS ON USE OF PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM
    ANDERSON, FA
    WHEELER, HB
    GOLDBERG, RJ
    HOSMER, DW
    FORCIER, A
    PATWARDHAN, NA
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (06) : 669 - 677
  • [3] PHYSICIAN PRACTICES IN THE PREVENTION OF VENOUS THROMBOEMBOLISM
    ANDERSON, FA
    WHEELER, HB
    GOLDBERG, RJ
    HOSMER, DW
    FORCIER, A
    PATWARDHAN, NA
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) : 591 - 595
  • [4] Antithrombotic therapy for venous thromboembolic disease
    Büller, HR
    Agnelli, G
    Hull, RD
    Hyers, TA
    Prins, AH
    Raskob, GE
    [J]. CHEST, 2004, 126 (03) : 401S - 428S
  • [5] Prevention of venous thromboembolism
    Clagett, GP
    Anderson, FA
    Geerts, W
    Heit, JA
    Knudson, M
    Lieberman, JR
    Merli, GJ
    Wheeler, HB
    [J]. CHEST, 1998, 114 (05) : 531S - 560S
  • [6] PREVENTION OF VENOUS THROMBOEMBOLISM
    CLAGETT, GP
    ANDERSON, FA
    HEIT, J
    LEVINE, MN
    WHEELER, HB
    [J]. CHEST, 1995, 108 (04) : S312 - S334
  • [7] Predictors of recurrence after deep vein thrombosis and pulmonary embolism -: A population-based cohort study
    Heit, JA
    Mohr, DN
    Silverstein, MD
    Petterson, TM
    O'Fallon, WM
    Melton, LJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (06) : 761 - 768
  • [8] Venous thromboembolism: disease burden, outcomes and risk factors
    Heit, JA
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (08) : 1611 - 1617
  • [9] Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home
    Koopman, MMW
    Prandoni, P
    Piovella, F
    Ockelford, PA
    Brandjes, DPM
    vanderMeer, J
    Gallus, AS
    Simonneau, G
    Chesterman, CH
    Prins, MH
    Bossuyt, PMM
    deHaes, H
    vandenBelt, AGM
    Sagnard, L
    DAzemar, P
    Buller, HR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) : 682 - 687
  • [10] A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
    Levine, M
    Gent, M
    Hirsh, J
    Leclerc, J
    Anderson, D
    Weitz, J
    Ginsberg, J
    Turpie, AG
    Demers, C
    Kovacs, M
    Geerts, W
    Kassis, J
    Desjardins, L
    Cusson, J
    Cruickshank, M
    Powers, P
    Brien, W
    Haley, S
    Willan, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) : 677 - 681